Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Online First

August 24, 2019

Correspondence
Novel NLRP12 variant presenting with familial cold autoimmunity syndrome phenotype
Free

Latika Gupta, Sakir Ahmed, Bharati Singh, Satya Prakash, Shubha Phadke, Amita Aggarwal

doi: 10.1136/annrheumdis-2019-216158

August 21, 2019

Correspondence
Chronic hydroxychloroquine exposure and the risk of Alzheimer’s disease
Free

Shih-Wei Lai, Yu-Hung Kuo, Kuan-Fu Liao

doi: 10.1136/annrheumdis-2019-216173

August 20, 2019

Correspondence response
Response to ‘Steroid sparing effect: an essential element in assessing therapeutic efficacy in SLE: response to ‘Time to change the primary outcome of lupus trials’ by Houssiau’ by Oon et al
Free

Frederic A Houssiau

doi: 10.1136/annrheumdis-2019-216160

August 17, 2019

Correspondence
Risk of gout flares after vaccination
Free

Shih-Wei Lai, Yu-Hung Kuo, Kuan-Fu Liao

doi: 10.1136/annrheumdis-2019-216146

August 16, 2019

Correspondence response
Fostering the application of the MS score in systemic juvenile idiopathic arthritis. Response to: ‘MS score in systemic juvenile idiopathic arthritis: suitable for routine use?’ by Chi et al
Free

Francesca Minoia, Angelo Ravelli

doi: 10.1136/annrheumdis-2019-216067
Correspondence
Steroid sparing effect: an essential element in assessing therapeutic efficacy in SLE: response to ‘Time to change the primary outcome of lupus trials’ by Houssiau
Free

Shereen Oon, Molla Huq, Mandana Nikpour

doi: 10.1136/annrheumdis-2019-216113
Correspondence
Ultrasonographic damages of major salivary glands are associated with cryoglobulinemic vasculitis and lymphoma in primary Sjogren’s syndrome: are the ultrasonographic features of the salivary glands new prognostic markers in Sjogren's syndrome?
Free

Guillaume Coiffier, Amélie Martel, Jean-David Albert, Alain Lescoat, Aurore Bleuzen, Aleth Perdriger, Michel De Bandt, François Maillot

doi: 10.1136/annrheumdis-2019-216122

August 03, 2019

Correspondence
Standardisation of myositis-specific antibodies: where are we today?
Free

Michael Mahler, Jean-Baptiste Vulsteke, Xavier Bossuyt, Ellen De Langhe, Minoru Satoh

doi: 10.1136/annrheumdis-2019-216003
Correspondence
Anti-Ku syndrome with elevated CK: association with myocardial involvement in systemic sclerosis
Free

Corrado Campochiaro, Giacomo De Luca, Maria De Santis

doi: 10.1136/annrheumdis-2019-216070

August 02, 2019

Correspondence
MS score in systemic juvenile idiopathic arthritis: suitable for routine use?
Free

Huihui Chi, Zhihong Wang, Chengde Yang, Yutong Su

doi: 10.1136/annrheumdis-2019-216041

June 12, 2019

Correspondence
Drug-induced systemic lupus erythematosus: should immune checkpoint inhibitors be added to the evolving list?
Free

Emanuel Raschi, Ippazio Cosimo Antonazzo, Elisabetta Poluzzi, Fabrizio De Ponti

doi: 10.1136/annrheumdis-2019-215819

May 10, 2019

Correspondence
How to use the Lupus Low Disease Activity State (LLDAS) in clinical trials
Free

Ioannis Parodis, Mandana Nikpour

doi: 10.1136/annrheumdis-2019-215650

April 16, 2019

Correspondence
Aortic dilatation in a patient with Takayasu arteritis treated with tocilizumab
Free

Francesco Muratore, Carlo Salvarani

doi: 10.1136/annrheumdis-2019-215459

Pages